[Code of Federal Regulations] [Title 21, Volume 6] [Revised as of January 1, 2003] From the U.S. Government Printing Office via GPO Access [CITE: 21CFR558.325] [Page 423-424] TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS--Table of Contents Subpart B--Specific New Animal Drugs for Use in Animal Feeds Sec. 558.325 Lincomycin. (a) Approvals. Type A articles and Type B feeds approved for sponsors in Sec. 510.600(c) of this chapter for specific uses as in paragraph (d) of this section as follows: (1) No. 000009 for 20 and 50 grams per pound. (2)-(4) [Reserved] (5) No. 043733 for 8 and 20 grams per pound. (6)-(12) [Reserved] (13) No. 017800 for 2.5 and 8 grams per pound. (14)-(15) [Reserved] (b) Related tolerances. See Sec. 556.360 of this chapter. (c) [Reserved] (d) Conditions of use--(1) Chickens. It is used in feed as follows: ------------------------------------------------------------------------ Lincomycin Indications for grams/ton use Limitations Sponsor ------------------------------------------------------------------------ (i) 2 Broilers: For As lincomycin 000009 control of hydrochloride necrotic monohydrate. enteritis caused by Clostridium spp. or other susceptible organisms. ------------------------------------------------------------------------ (ii) 2 to 4 Broilers: For As lincomycin 000009 increased rate of hydrochloride weight gain and monohydrate. improved feed efficiency. ------------------------------------------------------------------------ (2) Swine. It is used in feed as follows: ------------------------------------------------------------------------ Lincomycin Indications for grams/ton use Limitations Sponsor ------------------------------------------------------------------------ (i) 20 Growing-finishing Feed as sole ration. 000009 swine: For Not to be fed to increased rate of swine that weigh weight gain. more than 250 pounds (lb). ------------------------------------------------------------------------ (ii) 40 1. For control of Feed as sole ration; 000009 swine dysentery. for use in swine on 017800 premises with a 043733 history of swine dysentery but where symptoms have not yet occurred, or following use of lincomycin at 100 grams (g)/ton for treatment of swine dysentery. Not to be fed to swine that weigh more than 250 lb. 2. For control of Feed as sole ration, 000009 porcine or following use of proliferative lincomycin at 100 g/ enteropathies ton for control of (ileitis) caused porcine by Lawsonia proliferative intracellularis. enteropathies (ileitis). Not to be fed to swine that weigh more than 250 lb. ------------------------------------------------------------------------ (iii) 100 1. For treatment Feed as sole ration 000009 of swine for 3 weeks or until 017800 dysentery. signs of disease 043733 disappear. Not to be fed to swine that weigh more than 250 lb. 2. For control of Feed as sole ration 000009 porcine for 3 weeks or until proliferative signs of disease enteropathies disappear. Not to be (ileitis) caused fed to swine that by Lawsonia weigh more than 250 intracellularis. lb. ------------------------------------------------------------------------ (iv) 200 For reduction in Feed as sole ration 000009 the severity of for 3 weeks. Not to 017800 swine mycoplasmal be fed to swine that pneumonia caused weigh more than 250 by Mycoplasma lb. hyopneumoniae. ------------------------------------------------------------------------ (3) Lincomycin may also be used in combination with: (i) Amprolium and ethopabate or amprolium and ethopabate with roxarsone in accordance with Sec. 558.58. (ii) Clopidol in accordance with Sec. 558.175. (iii) Decoquinate in accordance with Sec. 558.195. (iv) Fenbendazole as provided in Sec. 558.258. (v) Halofuginone in accordance with Sec. 558.265. (vi) Ivermectin as in Sec. 558.300. [[Page 424]] (vii) Lasalocid alone or with roxarsone in accordance with Sec. 558.311. (viii) Monensin alone or with roxarsone in accordance with Sec. 558.355. (ix) Nicarbazin alone or with narasin or roxarsone as in Sec. 558.366. (x) Pyrantel as in Sec. 558.485. (xi) Robenidine in accordance with Sec. 558.515. (xii) Roxarsone in accordance with Sec. 558.530. (xiii) Salinomycin with or without roxarsone as in Sec. 558.550. (xiv) Zoalene in accordance with Sec. 558.680. [40 FR 13959, Mar. 27, 1975] Editorial Note: For Federal Register citations affecting Sec. 558.325, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and on GPO Access.